Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Xizang Weixinkang Pharmaceutical(603676) the Revenue is 322.14 M (+8.9%);the EBIT is 77.29 M (-12.88%);the EPS is 0.16 (-20%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.32B8.90%
----
----
EBIT
0.08B12.88%
----
----
EPS
0.1620.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf